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Supramolecular chemistry has been employed
to develop flexible and adaptable multivalent
neoglycoconjugates for binding galectin-1
(Gal-1). Gal-1, a dimeric lectin with two galacto-
side-binding sites, regulates cancer progression
and immune responses. Self-assembled pseu-
dopolyrotaxanes consisting of lactoside-dis-
playing cyclodextrin (LCD) ‘‘beads’’ threaded
onto polyviologen ‘‘strings’’ display mobile li-
gands as a result of cyclodextrin rotation about,
and limited translation along, the polymer chain.
The pseudopolyrotaxanes rapidly and efficiently
precipitate Gal-1 and provide valency-corrected
enhancements of up to 30-fold compared to na-
tive lactose and 20-fold over free LCD in a T-cell
agglutination assay. A supramolecular statistical
effect was observed, wherein the efficacy of
Gal-1 inhibition correlates with the number of
ligands connected to each other solely through
mechanical and noncovalent interactions. Such
flexible and adaptable self-assembled pseudo-
polyrotaxanes show promise for the study of
multivalent interactions and targeting of thera-
peutically relevant lectins.
INTRODUCTION
As the static, lock-and-key view of ligand-receptor com-
plexes gives way to more dynamic models [1], the role
of flexibility and adaptability in both one-to-one and multi-
valent binding events has emerged as a major question in
the field of molecular recognition. Multivalent interactions
[2, 3] are especially prevalent in glycobiology [4–7], where
high-avidity interactions take place between multimeric
and/or membrane-bound carbohydrate-binding proteins
(lectins) and their cognate carbohydrate ligands (epi-
topes), despite the low affinity provided by a typical mono-1140 Chemistry & Biology 14, 1140–1151, October 2007 ª2007valent interaction between a lectin and its epitope. The
fast on- and off-rates of the individual interactions and
the fact that many multivalent protein-carbohydrate inter-
actions take place at the fluid and dynamic interface of the
cell surface [8] suggest that flexibility and adaptability may
play important roles in these interactions.
Glycobiology and, in a more general sense, all of bio-
chemistry are conceptually related to the field of supramo-
lecular chemistry, through the shared focus on molecular
recognition and assembly [9, 10]. However, few of the
growing classes of synthetic supramolecular assemblies
[3, 9–11], such as pseudorotaxanes (ring around a thread)
and pseudopolyrotaxanes (many rings around a thread),
and related mechanically interlocked molecules [11–13],
such as rotaxanes (ring around a dumbbell-shaped
thread), catenanes (ring threaded through another ring),
and polyrotaxanes (many rings on a dumbbell-shaped
component), have been examined in biochemical con-
texts [14–18]. Recently, we [19–21] and Yui and coworkers
[22–25] have used supramolecular chemistry to develop
architectures for multivalent binding that are at the flexible
and adaptable end of the ligand-display spectrum.
Chemists have synthesized a large variety [26–36] of
neoglycoconjugates ranging from small molecules to
macro- and supramolecular entities in attempts to under-
stand, mimic, and perturb natural, multivalent lectin-
carbohydrate interactions. Factors [30–33] such as rigid-
ity, spacing, topology, and density of saccharides are
known to influence the avidity of multivalent, carbohy-
drate-displaying structures for their respective lectins.
Lehn and coworkers have utilized dynamic combinatorial
chemistry [34] to select trivalent neoglycoconjugates for
the lectin concanavalin A. Other promising approaches
that exploit multivalency for lectin binding include neogly-
copolymers [4, 27, 29, 31] and dynamic self-assembled
systems [26, 35, 36], such as micelles and liposomes.
Carbohydrate-displaying (pseudo)polyrotaxanes [19–24]
potentially combine advantages from both of these ap-
proaches for multivalent ligand presentation, including
(1) the ability to span large distances, (2) easily variable li-
gand densities, (3) adaptability, and (4) ease of synthesis
through self-assembly. Both our system [19–21] and thoseElsevier Ltd All rights reserved
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Galectin-1 and Multivalent Pseudopolyrotaxanesof Yui and coworkers [22–24] are based on the pioneering
work of Harada [37] and Wenz [38] on cyclodextrin (CD)-
based (pseudo)polyrotaxanes (recently reviewed in [39]).
CDs are naturally occurring, cyclic oligosaccharides
comprised of six, seven, or eight glucopyranoside units.
Although many of the exotic structures produced by su-
pramolecular chemists are incompatible with aqueous
media, CDs are well known to encircle hydrophobic mole-
cules in water. In many cases, the encapsulated products,
even large (pseudo)polyrotaxanes [39], retain water solu-
bility. In such ‘‘beads-on-a-string’’ architectures, the CD
rings are able to spin around the axis of the polymer chain
as well as move back and forth along the polymer back-
bone. The extent of these movements can be varied by
the choice of polymer chain [19, 24, 37–39]. If one con-
siders a ligand attached to each CD ring, the position of
this ligand is, to a large extent, independent of the position
of a ligand on a neighboring ring; although the ligands are
bound via noncovalent interactions of the CD rings with
the encircled polymer backbone, they are not directly
covalently bound to each other. Both ligands will have
considerable freedom, including up to 360 of rotation,
to respond to a receptor. Using lactoside-displaying
a-CD rings and a polyviologen backbone, we have re-
cently described a self-assembled, multivalent pseudo-
polyrotaxane [20] that was used to target galectin-1
(Gal-1) [8, 40–44], a bivalent galactoside-binding lectin.
Gal-1 is a soluble, 14 kDa dimeric lectin whose natural
ligands typically, but not exclusively [45],reside on cellular
membranes. Gal-1 binding mediates the organization [5,
6, 8] of cell-surface glycoproteins through crosslinking of
terminal or polymeric N-acetyllactosamine residues.
Gal–1 is the prototypical member of the galectins [44–
49], a ubiquitous family of galactoside-binding lectins
that mediate cell adhesion, signaling, and death. Certain
galectins, particularly Gal-1 and Gal-3, are overexpressed
in a variety of cancers [43, 44, 48, 49]. In addition to pro-
moting motility and metastasis [46], certain cancer cells
are able to use Gal-1 as a self-defense mechanism [42,
43] by taking advantage of the natural function [41, 47]
of Gal-1 as an apoptotic signal for T- and other cells of
the immune system. Topologically, Gal-1 presents a par-
ticularly interesting challenge for targeting with synthetic,
multivalent ligands (recently reviewed in [44]) since it is a
rigid dimer [40] with two binding sites oriented in opposite
directions such that the entrance to each of the binding
sites is located 6 nm apart. Since the biological targets
of Gal-1 reside on the cell surface, one strategy for target-
ing Gal-1 is to use structures that mimic the fluidity and
adaptability of cellular membranes.
In our original report [20], a pseudopolyrotaxane (Fig-
ure 1A) composed of a polyviologen chain with, on
average, 17 repeating units, over 90% threaded with
lactoside-displaying CDs (LCDs), proved effective at tar-
geting Gal-1. The pseudopolyrotaxane displays highly
mobile ligands as a result of CD rotation about, and limited
translation along, the polymer chain. Multivalent enhance-
ments of 6.7-fold and 10-fold relative to the free lactoside-
CD and free lactose, respectively, were obtained for theChemistry & Biology 14, 1140–1inhibition of Gal-1 in a T-cell agglutination assay. This
valency-corrected enhancement was greater than that
observed for lactoside-bearing, trivalent glycoclusters
and a fully covalent (chitosan-based) polymer tested by
using the same assay. Herein, we investigate these multi-
valent interactions between Gal-1 and lactoside-display-
ing supramolecular assemblies further by using T-cell
agglutination and quantitative precipitation assays to
evaluate pseudopolyrotaxanes with different degrees of
threading and different polyviologen chain lengths.
RESULTS AND DISCUSSION
Supramolecular Assemblies
Polyviologen AB-copolymers, consisting of alternating
decamethylene (A) and positively charged bipyridinium
(B) segments, form [20, 37–39] stable, water-soluble com-
plexes with a-CD, wherein the positive charges, associ-
ated formally with the nitrogen atoms on the bipyridinium
segments of the polymer, act as electronic ‘‘speed
bumps’’ [39, 50] that reduce the translational motion of
the CD rings. In aqueous solution, the a-CD rings thread
onto the polymer chain and rest predominantly on its deca-
methylene segments, stabilized by the hydrophobic in-
teractions inside the cavities of the CDs. By separating
the hydrophobic segments into domains flanked by
‘‘speed bumps,’’ polyviologens can support high levels
of threading at equilibrium, with the timescale of self-
assembly being relatively slow (3–30 days), due to the
necessity of the a-CD rings passing over multiple bipyridi-
nium segments. For example, in the self-assembly of the
pseudopolyrotaxane from our previous report [20], a mix-
ture of 17 equivalents of LCD (20 mM) with a polyviologen
containing, on average, 17 repeating units (PV-17) re-
sulted in over 90% threading. This assembly is henceforth
designated [17:17], in which the number to the left of the
colon indicates the equivalents of ring to thread in the so-
lution (not necessarily on the polyviologen backbone), and
the number to the right of the colon indicates the average
number of polyviologen repeating units in the backbone
(i.e., 17 for PV-17). The actual degree of threading
(>90%) was estimated from 1H-NMR spectroscopy and
thin-layer chromatography. It was also reported that
a 50-fold dilution resulted in no change in the 1H-NMR
spectrum even after a week. As described elsewhere
[21], there is now reason to believe that the results of
this original 1H-NMR dilution experiment are not general.
In the course of developing a quantitative precipitation as-
say (vide infra), we had the occasion to subject these
pseudopolyrotaxanes to the Bradford assay [51] (Bio-
Rad), a well-known analytical method for quantifying pro-
tein concentrations based on a blue shift in the absorption
spectra of the dye, Coomassie Blue. This assay resulted in
several surprising discoveries [21]: (1) free polyviologens
are responsive to the Bradford assay, which is usually
highly selective for proteins; (2) for pseudopolyrotaxanes
derived from polyviologens, the response of the Bradford
assay was dependent on, and thus indicative of, the de-
gree of threading; and using this simple colometric assay151, October 2007 ª2007 Elsevier Ltd All rights reserved 1141
Chemistry & Biology
Galectin-1 and Multivalent PseudopolyrotaxanesFigure 1. Self-Assembled, Multivalent Pseudopolyrotaxanes
(A) Schematic representation of pseudopolyrotaxanes composed of lactoside-displaying cyclodextrin (LCD) rings and polyviologen threads. Chem-
ical structures of the components are also shown.
(B) Table describing the degree of threading for a series of pseudopolyrotaxane assemblies. aDilution to 1 mM polyviologen repeating unit. ‘‘TBA%,’’
the degree of threading, as measured by the Bradford assay, is defined as: 1003 (1  [OD595 sample  OD595 background]/[OD595 free PV  OD595
background]). The values in the table are reproduced from a full account [21] of the development of the assay. Using the first entry as an example, this
pseudopolyrotaxane was self-assembled from a ratio of five LCDs to each PV-21 thread, hence the nomenclature [5:21]. Since the thread has, on
average, 21 polyviologen repeating units, this assembly is expected to be quarter-threaded at equilibrium after self-assembly, which is in good agree-
ment with themeasured TBA of 23% for the stock solution (20mM in LCD). Upon dilution, equilibrium is reestablished (R2 days) with a TBA of 13% for
this assembly, but this dethreading is not yet significant at 4 hr after dilution (22% TBA).as a reporter, (3) dethreading was observed for diluted so-
lutions of the pseudopolyrotaxanes upon standing. Al-
though these pseudopolyrotaxanes do not appear to be
as thermodynamically stable to dilution as previously sup-
posed, they are kinetically stable on the timescale (15 min)
of the T-cell agglutination assays. As a result of the elec-
tronic speed bumps provided by the viologen units, it
can take up to 2 days to reach equilibrium upon dilution;
initial dethreading is observed, however, on the timescale
(3 hr) of the precipitation experiments presented herein.
The polyviologens PV-8 and PV-21 were synthesized
according to literature precedent [50]. The number aver-
age molecular weights (Mn = 3650 and 9581), which
were determined (end-group analysis) by 1H-NMR spec-
troscopy, correspond to an average of 8 and 21, respec-1142 Chemistry & Biology 14, 1140–1151, October 2007 ª2007tively, repeating AB units. PV-21 is somewhat longer
than the previously reported PV-17, whereas PV-8 is con-
siderably shorter. Seven solutions (Figure 1B) were pre-
pared with 20mM LCD in H2O and different amounts of ei-
ther PV-8 or PV-21. With an equal number of rings to
repeating units, solutions [21:21] and [8:8] are expected
to contain nearly fully threaded pseudopolyrotaxanes
and few free LCDs.With (roughly) half asmany rings as re-
peating units, solutions [10:21] and [4:8] are expected to
be nearly half-threaded, whereas [5:21] and [2:8], with
(roughly) a quarter of the rings to repeating units, are
expected to be quarter-threaded. By contrast, solution
[42:21] contains twice as many rings as repeating units;
thus, it should contain a (very nearly) fully threaded pseu-
dopolyrotaxane and a full equivalent of free LCD. ResultsElsevier Ltd All rights reserved
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Galectin-1 and Multivalent Pseudopolyrotaxanesfrom the Bradford assay are shown in Figure 1B as TBA
(Threading by Bradford Assay) percentages [21] for these
solutions at the concentration (20 mM LCD) used for self-
assembly. Note that the TBA percentages correlate ex-
tremely well with our expectations of threading by the
PV-21-derived pseudopolyrotaxanes and also report—
apparently overestimating—the degree of threading for
PV-8-derived pseudopolyrotaxanes. The aqueous solu-
tions of self-assembled pseudopolyrotaxanes (20 mM
LCD) were used as stock solutions for the T-cell agglutina-
tion and quantitative precipitation experiments, which
were performed immediately after dilution unless other-
wise noted. Diluted solutions of the pseudopolyrotaxanes
experienced dethreading upon standing, as observed by
lower TBA percentages (Figure 1B, dilution to 1 mM poly-
viologen repeating unit), which correlated with decreased
activity in functional assays (vide infra). Note that assem-
bly [21:21], for which this concentration is a 20-fold dilu-
tion in both LCD and PV-21, goes from 87% to 52%
TBA and reaches equilibrium in 2 days, whereas assembly
[42:21], which contains the full extra equivalent of LCD, is
much more resistant to dethreading. (Dynamic unthread-
ing and rethreading will occur for all of the assemblies,
but for [42:21], the extra equivalent of LCD shifts the equi-
librium toward the nearly fully threaded state, with 85%
TBA observed after 2 days.) Although some dethreading
is observed for all pseudopolyrotaxanes after 2 days,
[21:21], [10:21], [8:8], and [4:8] show noticeable deth-
reading after only 4 hr.
Quantitative Precipitation Assay
It is well established that multivalent lectins and carbohy-
drates can induce each other to precipitate [5, 6, 30, 31]. If
it is possible to distinguish between the lectin and carbo-
hydrate portion of the precipitate, quantitative precipita-
tions [52] can be performed to gain such information as
the ratio of lectin to carbohydrate in the precipitate. The
Bradford assay was used as a protein-specific reporter,
whereas UV spectroscopy provides the total amount of
both protein and polymer in the solution and in the precip-
itate (see Experimental Procedures for details). The re-
sponsiveness of the pseudopolyrotaxanes themselves to
the Bradford assay [21] limits our ability to quantify precip-
itation results by this method to those concentrations and
degrees of threading that do not yield a significant Brad-
ford response. However, at concentrations relevant to
the precipitation assay, many of the assemblies and, in
particular, the highly effective [21:21] and [42:21] do not
yield a Bradford response above background; thus, in
these cases, the assay can be used to report solely on
protein concentration in the presence of pseudopolyro-
taxane.
Neither the pseudopolyrotaxanes, their components,
nor recombinant human Gal-1 [53] precipitate on their
own, at least during the timescale of these experiments.
The individual pseudopolyrotaxane components, LCD,
PV-8, and PV-21, do not induce Gal-1 to precipitate.
With the pseudopolyrotaxanes, precipitation (Figure 2A)
is rapid, as determined visually or by light scattering (seeChemistry & Biology 14, 1140–11the Supplemental Data available with this article online).
A white precipitate is clearly visible within the first minute
of mixing for concentrations such as 4:1 polyviologen
repeating unit of assembly [21:21]:Gal-1 (50 mM). As it oc-
curs readily in both polypropylene Eppendorf tubes and
polysyrene 96-well plates, precipitation was not depen-
dent on a particular type of surface. After mixing, solutions
were left for at least 3 hr before the solution was separated
from the precipitate (all precipitations are likely to be com-
plete at 2 hr, based on light scattering). The precipitate
was then dissolved in 0.5 M lactose for analysis by the
Bradford assay and UV spectroscopy. Lactose was also
immediately added to the separated solution, to prevent
additional aggregation/precipitation phenomena that
would otherwise occur as equilibrium is reestablished
after the removal of the precipitate.
The pseudopolyrotaxanes efficiently precipitate Gal-1
(Figure 2A); assembly [21:21] induces over 80%precipita-
tion at a 4:1 starting ratio of the polyviologen repeating unit:
Gal-1, which results in a 2:1 ratio of polyviologen repeating
unit:Gal-1 in the precipitate. This 2:1 ratio (Figure 2B) is rel-
atively constant over a 10-fold titration range of assembly
[21:21] relative to a fixed concentration of Gal-1. This
suggests that a crosslinking Gal-1 occupies every other
potential binding site in the precipitated pseudopolyrotax-
ane-lectin aggregates. See Figure 2C for an idealized
model of the precipitate. This ratio of polyviologen repeat-
ing unit:Gal-1 in the precipitate can be driven to nearly 1:1,
with an excess of Gal-1 relative to the polyviologen re-
peating units (Figure 2B). Note that this ratio is not ex-
pected to hit exactly 1:1, given that not every repeating
unit of the polyviologen backbone will be occupied by
an LCD. Normalized to the concentration of polyviologen
repeating units, assemblies [8:8], (Figure 3A) [10:21], and
[5:21] were all less efficient at precipitating Gal-1 than as-
sembly [21:21] (Figure 3B). However, assembly [42:21],
which contains an extra LCD for every polyviologen re-
peating unit, was somewhat more efficient than assembly
[21:21] (Figure 3B). This result was a surprising one, since
free LCDs were initially expected to detract from precipi-
tation efficiency. The precipitates from assembly [42:21]
displayed Gal-1:polyviologen repeating unit ratios close
to 1:1, even at excess polyviologen repeating unit:Gal-1
ratios. This observation reflects the increased likelihood
of each polyviologen repeating unit to be threaded in as-
sembly [42:21], especially considering its resistance to
dethreading, compared with the propensity of pseudo-
polyrotaxane [21:21] to dethread over relatively short
timescales (Figure 1B). This increased propensity to be
threaded most likely accounts for the increased precipita-
tion efficiency of pseudopolyrotaxane [42:21], overcom-
ing, or perhaps even aided by, the equivalent of free
LCD. While a large excess of free lactoside inhibits and re-
verses precipitation, one equivalent could aid precipita-
tion by breaking up unproductive aggregates/chelates in
favor of those more prone to precipitate.
Precipitation occurs on a timescale that is competitive
with at least the beginnings of dethreading. Dethreading
prior to exposure to Gal-1 can limit the effectiveness of51, October 2007 ª2007 Elsevier Ltd All rights reserved 1143
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Galectin-1 and Multivalent PseudopolyrotaxanesFigure 2. Quantitative Precipitation Assay of Pseudopolyrotaxane [21:21] with Gal-1
(A) Chart describing the concentrations of Gal-1 and pseudopolyrotaxane [21:21] in the precipitates obtained from two separate titrations. On the left,
increasing concentrations of pseudopolyrotaxane [21:21] as well as its components LCD and PV-21weremixed with a fixed concentration (50 mM) of
Gal-1. On the right, increasing concentrations of Gal-1 were mixed with a fixed concentration (50 mM) of pseudopolyrotaxane [21:21]. The concen-
trations of pseudopolyrotaxane [21:21] indicated are per polyviologen repeating unit. Error bars indicate the standard deviation.
(B) Chart comparing the ratio of Gal-1 to pseudopolyrotaxane [21:21] in the precipitates obtained from both titrations. Error bars indicate the standard
deviation.
(C) Idealized model of precipitate highlighting the 2:1 ratio of polyviologen repeating units:Gal-1 found in the precipitate across a 10-fold range of
starting pseudopolyrotaxane [21:21] concentrations.precipitation, as was observed when diluted solutions of
assembly [21:21] were allowed to stand for 3 hr before
a precipitation experiment was begun, which resulted in
a small, but noticeable, decrease in the amount of Gal-1
precipitated—70%with a 4:1 ratio of polyviologen repeat-
ing unit:Gal-1 for [21:21] (data not shown). Once exposed
to Gal-1, crosslinking almost certainly alters the dethread-
ing kinetics and thermodynamics.1144 Chemistry & Biology 14, 1140–1151, October 2007 ª200T-Cell Agglutination Assay
A straightforward assay [20] based on the ability of Gal-1
to aggregate T cells was employed to evaluate the pseu-
dopolyrotaxanes. Treatment of CEM cells—cultured hu-
man T-leukemia cells—with 10 mM recombinant human
Gal-1 [53] for 5 min at 37C results in large aggregates
that resemble tumor emboli, whereas pretreating Gal-1
with lactosides for 10 min at room temperature results in7 Elsevier Ltd All rights reserved
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Galectin-1 and Multivalent PseudopolyrotaxanesFigure 3. Quantitative Precipitation Assay of Pseudopolyrotaxanes with Gal-1
(A) Chart describing the concentrations of Gal-1 and pseudopolyrotaxane [8:8] in the precipitates obtained from two separate titrations. On the left,
increasing concentrations of pseudopolyrotaxane [8:8] were mixed with a fixed concentration (50 mM) of Gal-1. On the right, increasing concentra-
tions of Gal-1 were mixed with a fixed concentration (50 mM) of pseudopolyrotaxane [8:8]. The concentrations of pseudopolyrotaxane [8:8] indicated
are per polyviologen repeating unit. Error bars indicate the standard deviation.
(B) Chart describing concentrations of Gal-1 and PV-21-based pseudopolyrotaxanes in the precipitates obtained from two separate titrations. On the
left, increasing concentrations of pseudopolyrotaxanes [42:21], [21:21], [10:21], and [5:21] were mixed with a fixed concentration (50 mM) of Gal-1.
On the right, increasing concentrations of Gal-1 were mixed with a fixed concentration (50 mM) of each pseudopolyrotaxane. The concentrations of
pseudopolyrotaxanes indicated are per polyviologen repeating unit. Error bars indicate the standard deviation.either similar aggregates, amixed state of aggregated and
dispersed cells, or mostly dispersed cells (Figures 4G, 4D,
and 4A, respectively, for example). The lowest value of
lactoside for which the mixed state is observed is defined
as the minimum inhibitory concentration (MIC). Inhibition
has been shown [20] to be lactoside dependent, because
free polyviologens or polyviologens threaded with native
a-CD are not inhibitors. The PV-21- and PV-8-based as-
semblies, always freshly diluted into PBS buffer from the
H2O stock solution, were subjected to the agglutination
assay (Figures 4–6).
At an intermediate per-lactoside concentration of
300 mM (Figures 4D–4F), assemblies [4:21], [21:21], and
[42:21] have all yielded the mixed state. At 100 mM (Fig-
ures 4G–4I), which is the MIC of assembly [21:21]
(Figure 5A), the inhibitory affect of assembly [42:21],
which contains the extra equivalent of LCD and thusmight
be expected to be half as effective as assembly [21:21] on
a valency-corrected basis, has indeed been lost. By con-
trast, the quarter-threaded pseudopolyrotaxane [5:21] isChemistry & Biology 14, 1140–11still inhibitory. In fact, the pseudopolyrotaxane [5:21] dis-
plays a valency-correctedMIC of 50 mM (Figure 5A), which
is a 30-fold enhancement compared to lactose, a 20-fold
enhancement compared to free LCD, and 2-fold better
than the nearly fully threaded assembly [21:21], despite
having only one-quarter the number of available lactoside
ligands. The roughly half-threaded assembly [10:21]
yields the same MIC (100 mM) as the nearly fully threaded
assembly [21:21], confirming that, on a per-lactoside ba-
sis, it is not necessary to maximize the number of LCDs/
thread to attain the mixed state at a low concentration.
However, the lower-threaded assemblies [5:21] and
[10:21] attain the dispersed state only at higher concen-
trations (750 mM, valency corrected) than the more fully
threaded assemblies. As portrayed in Figures 4A–4C,
[21:21] and [42:21] have attained the dispersed state
at 600 mM (valency corrected), whereas [5:21] remains
in the mixed state at this concentration. The PV-8-based
assemblies also show that the more fully-threaded
systems attain the dispersed state more readily on a51, October 2007 ª2007 Elsevier Ltd All rights reserved 1145
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Galectin-1 and Multivalent PseudopolyrotaxanesFigure 4. T-Cell Agglutination Assay Light Microscopy, 103, Images of Titrations of Pseudopolyrotaxanes [42:21], [21:21], and
[5:21] in the Presence of CEM Cells and 10 mM Gal-1
(A–I) Valency-corrected lactoside concentrations are shown at the left. At 600 mM lactoside, cells are (A) dispersed for [42:21], (B) dispersed
for [21:21], and (C) in the mixed state for [5:21]. At 300 mM lactoside, cells are (D) in the mixed state for [42:21], (E) in the mixed state for [21:21],
and (F) in the mixed state for [5:21]. At 100 mM lactoside, cells are (G) aggregated for [42:21], (H) in the mixed state for [21:21], and (I) in the mixed
state for [5:21].valency-corrected basis, whereas the valency-corrected
MIC for each of these assemblies is the same (200 mM).
This result represents an enhancement of 7.5-fold versus
lactose and 5-fold versus LCD, i.e., significant gains, at
least for the quarter-threaded assembly [2:8], considering
there are only two lactoside ligands (on average) con-
nected in this pseudopolyrotaxane.
The multivalent enhancements (valency-corrected MIC)
for the full range of pseudopolyrotaxanes tested versus
MIC for free lactose and LCD are shown in Figure 5B.
The quarter-threaded 21-mer [5:21] is the best performer,
whereas assembly [42:21], in which half of the LCDs are
not located on a polymer backbone, is theworst; however,
it still generates a 4-fold enhancement compared to free
LCD or a 6-fold enhancement compared to lactose. The
nearly fully threaded [21:21] and half-threaded [10:21]
gave the same enhancement (10-fold versus LCD, 15-
fold versus lactose); thus, from the ‘‘perspective’’ of lacto-
side ligand, it does not matter whether the polyviologen
backbone is half or nearly fully threaded, although it is
more effective to be one-quarter threaded. Indeed, with
its valency-corrected enhancement of 20-fold compared
to the monovalent ligand (LCD), assembly [5:21] has the1146 Chemistry & Biology 14, 1140–1151, October 2007 ª20highest valency-corrected enhancement, of which we are
aware, for inhibition of Gal-1 in a cell-based assay. Gabius
and coworkers have achieved much greater enhance-
ments for Gal-1 binding, asmeasured in solid-phase com-
petition assays by using starburst glycodendrimers [54]
and wedge-shaped glycodendrons [55], synthesized by
Roy and coworkers and by Pieters and coworkers, re-
spectively. At least for the glycodendrons [55], the best
efficacy in a cell-based assay was on the same order of
magnitude (14.5-fold greater than monovalent lactoside)
as seen here for the potent pseudopolyrotaxanes.
There is an interesting progression observed for the
nearly fully threaded pseudopolyrotaxanes [21:21],
[17:17], and [8:8] correlating average polyviologen length
withmultivalent enhancement (10-, 6.7-, and 5-fold versus
LCD, respectively), i.e., from the lactoside ligand ‘‘per-
spective,’’ it is more effective to be on a longer polymer
thread, which allows for more noncovalently connected li-
gands and greater total bridgeable distances between the
lactosides. As noted, all three of the PV-8-based assem-
blies gave the same multivalent enhancement of 7.5-fold
versus lactose and 5-fold versus LCD. The PV-8-based
assemblies differentiate themselves when we consider07 Elsevier Ltd All rights reserved
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Galectin-1 and Multivalent PseudopolyrotaxanesFigure 5. Summary of Agglutination Assays
(A) Table relating the lowest value of inhibitor (in mM) necessary to obtain the dispersed and mixed states (MIC) on both a per-lactoside and per-
polymer basis. aValues from reference [20]. All titrations were performed at least in triplicate.
(B) Results of the agglutination assay presented as a chart of valency-corrected enhancements, with per-lactosideMIC normalized to theMIC for free
lactose (blue) and for free LCD (magenta).the polymer backbone (polyviologen) concentration at the
MIC, which ranges from 25 mM for assembly [8:8] to 100
mM for assembly [2:8]. For the PV-21-based assemblies
as well, from the ‘‘perspective’’ of the polyviologen back-
bone, the most effective assembly is the nearly fully
threaded [21:21], with an MIC of 4.8 mM on a per-polymer
basis. This value is half of the Gal-1 concentration (10 mM)
used in these experiments, and it represents an advantage
of 357-fold compared to lactose and 208-fold compared
to LCD on a multivalent, supramolecular complex to
monovalent ligand basis.
A comparison of the polymer concentrations at the low-
est values of the mixed and dispersed states for all pseu-
dopolyrotaxanes tested reveals a general trend toward
increasing efficacy with increased threading. Further-
more, by reorganizing the data in Figure 5A to Figure 6A
to highlight the number of ligands (LCDs) that may be non-
covalently connected to each other in each assembly,
regardless of the length of the polyviologen backbone,
a clear progression emerges in the values relating the
number of potentially connected ligands (average maxi-
mumnumber of LCDs/polymer) to the polymer concentra-
tion necessary to attain the dispersed state. Indeed,
expressed graphically (Figure 6B), the negative log of the
polymer concentration versus the log of the average max-Chemistry & Biology 14, 1140–1imum number of LCDs/polymer yields a reasonable linear
fit (R2 = 0.965), indicating that the ability to attain the dis-
persed state is described reasonably well by this one fac-
tor alone. The same trend exists for the mixed state, but
the correlation is much worse (R2 = 0.87), an observation
that indicates that other factors, presumably including
polymer length and ligand spacing, also strongly affect
the ability to attain themixed state. Additionally, the values
for the monovalent ligand LCD, shown at 0 on the graph
(log of 1), fall directly on the line for the dispersed state,
and far off the line for the mixed state. By definition, the
dispersed state must be at or near saturation of Gal-1-
binding sites by the pseudopolyrotaxanes, because there
is not enough free Gal-1 to cause substantial aggregation
of the T cells. It follows that, on a hypothetical binding
curve between Gal-1 and the pseudopolyrotaxanes, the
mixed state is a lower point on the curve, perhaps near
the hypothetical IC50. While it is notoriously problematic
[56] to relate the results of agglutination assays directly
to thermodynamic binding parameters, it is not surprising
that more subtle factors would be necessary to account
for binding near the hypothetical IC50 than near saturation.
Alternatively, the different dependence on the number of
connected ligands could imply a change in the mecha-
nism(s) of binding with increasing pseudopolyrotaxane151, October 2007 ª2007 Elsevier Ltd All rights reserved 1147
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Galectin-1 and Multivalent PseudopolyrotaxanesFigure 6. Supramolecular Statistical Effect: A Dependence on the Number of Noncovalently Connected Ligands
(A) Table highlighting the agglutination assay results—lowest values of inhibitor (in mM) necessary to obtain the dispersed and mixed states on a per-
polymer basis—as a function of the number of noncovalently connected ligands (average maximum number of LCDs/polymer).
(B) Graph of the log averagemaximum number of LCDs/polymer versus the negative log of the lowest polymer concentration necessary to obtain the
mixed and dispersed states. The linear fits reveal a better correlation for the dispersed state. The large outlier for the mixed state is assembly [5:21].concentration upon going from the mixed to dispersed
states.
A dependence on the number of connected ligands is
a hallmark of the statistical effect in multivalent binding
[2–7, 30, 31, 52, 56]. Here, the ligands are not connected
directly by traditional covalent bonds, but are mechani-
cally connected via the encircled polymer backbone.
Hence, we observe a supramolecular statistical effect for
these pseudopolyrotaxanes inhibiting Gal-1-mediated ag-
glutination of the T cells, particularly at the higher pseudo-
polyrotaxane concentrations necessary to obtain the
dispersed state. The observation of a supramolecular
statistical effect does not, in and of itself, define a mecha-
nism of binding; however, it is consistent with the simplest
possible mechanism: one-to-one binding between Gal-1
and a single pseudopolyrotaxane chain, in which only
one of the lactoside-binding sites is occupied at a time.
Another possible mechanism of binding is chelation,
whereby a single pseudopolyrotaxane chain provides lac-
tosides to both Gal-1-binding sites. Aggregation, which, in
this context, we explicitly define as crosslinking of dif-
ferent pseudopolyrotaxane chains by one or more Gal-1
dimers, is also likely to be a factor. Although the thermo-
dynamic driving forces behind protein-carbohydrate ag-
gregates are still not fully understood, the formation of
such aggregates has been suggested [56] to be a major1148 Chemistry & Biology 14, 1140–1151, October 2007 ª200factor in agglutination experiments. Furthermore, Gal-1
is an evolutionarily adapted crosslinker [4–6, 40], with a to-
pology that would bias aggregation over chelation. The
tendency of Gal-1 and the pseudopolyrotaxanes to aggre-
gate is clear from the light scattering and precipitation
experiments, albeit at different concentrations and ratios
than are present in the agglutination assay.
It would be particularly interesting to know whether the
pseudopolyrotaxanes chelate Gal-1. Chelation is often as-
sociated [2–7, 28, 30, 31, 33] with considerably greater
multivalent enhancements than are obtained by the statis-
tical effect alone. A traditional view [4, 7, 56] holds that
chelation would be disfavored for a flexible system that
will freeze out considerable entropy upon chelation, espe-
cially given the large distance between, and orientation of,
lactoside-binding sites in Gal-1. However, the incompati-
bility of chelation with flexible systems and long distances
between the potentially bridging ligands has been ques-
tioned [3, 57, 58] on experimental and theoretical grounds.
A definitive answer on the ability of the pseudopolyrotax-
anes to chelate Gal-1 and the relative importance of this
interaction to the overall binding energy will require a
more direct readout for thermodynamic binding parame-
ters. Nevertheless, deviations from the dependence on
just the number of connected ligands may reflect some
degree of chelation, because certain combinations of7 Elsevier Ltd All rights reserved
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should favor chelation. Considerations of bond lengths
and angles in the pseudopolyrotaxanes suggest that
chelation could occur for LCDs that are a minimum of
four polyviologen repeating units apart. This spacing is
intriguing because it is reasonable that the LCDs of
assembly [5:21] would be, on average, four repeating
units apart. This pseudopolyrotaxane is both the most
potent on a valency-corrected basis, and the largest out-
lier from the trend of simple dependence on the number of
connected ligands for the mixed state (Figure 6). Assem-
bly [5:21] also maintains the mixed state over a larger
concentration range than the more fully threaded pseudo-
polyrotaxanes (Figures 4 and 5A). Perhaps this range is
expanded by access to binding modes, particularly chela-
tion, that are less favored for the other pseudopolyrotax-
anes. In comparison with aggregation, for example, it is
interesting to consider how poorly pseudopolyrotaxane
[5:21] performed in the quantitative precipitation assay
(Figure 3B). Overall it is likely that the flexible and adapt-
able pseudopolyrotaxanes exhibit a variety of binding
modes with dimeric Gal-1, and that the distribution among
these binding modes changes with the degree of thread-
ing, which itself is a dynamic quantity.
Conclusions
Biology is replete with examples of individual proteins self-
assembling into superstructures wherein the complexes
gain or enhance functions with respect to those of the
individual components [9, 10]. Here, supramolecular spe-
cies formed from over 20 ([21:21] and [42:21]) or as few as
3 ([2:8]) self-assembling components have been used to
successfully precipitate the bivalent lectin Gal-1 and to
inhibit Gal-1 in T-cell agglutination assays. These self-
assembled pseudopolyrotaxanes are an example of the
kind of flexible and adaptable multivalent ligand display
that can be afforded through supramolecular chemistry.
The lactoside ligands are able to rotate freely and indepen-
dently around the polymer backbone, whereas the CDs
can translate within the confines of the decamethylene
units, which have a length that is twice the depth of
a CD cavity. Not only do the lactoside ligands have the
ability to ‘‘fine tune’’ their positions without enthalpic pen-
alties having to be paid on account of inducing strain, but
the unbound ligands may also reside away from the bulky
protein in order to reduce steric clashes. This flexibility and
adaptability may contribute to the speed, efficacy, and
large amount of Gal-1 captured by the pseudopolyrotax-
anes in the precipitations, as well as the supramolecular
statistical effect and efficacy observed in the agglutination
assay. These flexible and adaptable, multivalent supra-
molecular complexes show promise both for the study of
protein-carbohydrate interactions and the exploitation of
multivalency for targeting therapeutically relevant lectins.
SIGNIFICANCE
A key question acrossmany fields of molecular recog-
nition—and, in particular, glycobiology—is the degreeChemistry & Biology 14, 1140–1to which flexibility and adaptability contribute to
multivalent binding. Herein, we have described the
interactions of a series of self-assembled multi-
valent pseudopolyrotaxanes, consisting of lactoside-
displaying cyclodextrin (LCD) ‘‘beads’’ threaded onto
polyviologen ‘‘strings,’’ with a bivalent lectin, galec-
tin-1 (Gal-1). These supramolecular assemblies dis-
play highly flexible and adaptable ligands as a result
of rotation of the CD torus about, and limited transla-
tion along, the polymer chain. Seven assemblies with
different ratios of ‘‘beads’’ threading two different
length polyviologen ‘‘strings’’ have been prepared.
The pseudopolyrotaxanes rapidly and efficiently
precipitate Gal-1; over 80% precipitation of Gal-1 is
observed. The ratio of Gal-1:polyviologen repeating
unit in the precipitate can approach 1:1, i.e., nearly ev-
ery potential binding site is occupied by a crosslinking
Gal-1 in the precipitated pseudopolyrotaxane-lectin
aggregates. A supramolecular statistical effect was
observed in a T-cell agglutination assay, wherein the
efficacy of Gal-1 inhibition correlates with the number
of ligands connected to each other solely through
mechanical and noncovalent interactions. Also, in
this assay, valency-corrected enhancements of up to
30-fold compared to native lactose and 20-fold com-
pared to free LCD, as well as per-polymer enhance-
ments of up to 357- and 208-fold compared to native
lactose and free LCD, respectively, were obtained.
These results show that synthetic supramolecular
complexes are useful tools for the study of multivalent
protein-carbohydrate interactions and, more broadly,
suggest that the conceptually related, but, in practice,
often disparate, fields of biochemistry and supra-
molecular chemistry have much to offer each other.
EXPERIMENTAL PROCEDURES
General
LCD [19], assembly [17:17] (pseudopolyrotaxane 3 in reference [20]),
and details of the agglutination assay [20] with CEM cells (subclone
of ATCC no. CCL-119) and recombinant human Gal-1 [53] have
been previously described. Polyviologens PV-8 and PV-21 were
synthesized according to literature precedent [20, 50]; for details and
characterization, see the Supplemental Data. The use of the Bradford
assay to monitor the degree of threading for these pseudopolyrotax-
anes has been described in detail separately [21].
Pseudopolyrotaxanes
Stock solutions (20 mM LCD in H2O) of assemblies [5:21], [10:21],
[21:21], and [42:21] were prepared in 1.5 ml Eppendorf tubes by dis-
solving LCD (10 mmol) and varying quantities of PV-21 (42, 21, 10, and
5 mmol, respectively) in 500 ml H2O. Stock solutions (20 mM LCD in
H2O) of assemblies [2:8], [4:8], and [8:8] were prepared in 1.5 ml
Eppendorf tubes by dissolving LCD (10 mmol) and varying quantities
of PV-8 (40, 20, and 10 mmol, respectively) in 500 ml H2O. The pseudo-
polyrotaxanes self-assembled upon standing (1 month) prior to the
initiation of biochemical experiments. The degree of threading in these
assemblies was monitored by using the Bradford assay [21].
Quantitative Precipitation
Precipitation reactions were conducted in 1.5 ml Eppendorf
tubes and initiated by mixing human recombinant Gal-1 [53] with151, October 2007 ª2007 Elsevier Ltd All rights reserved 1149
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2 and 3, in total volumes of 150 ml PBS-buffered solution. After initial mix-
ing, the tubes were allowed to sit for 3 hr and then centrifuged for 10min
at 14,000 rpm. The 150 ml solutions were then transferred to new 1.5 ml
Eppendorf tubes (henceforth S-tubes), and 150 ml lactose solution (0.5M
lactose in PBS) was added to both sets of tubes, which were then vor-
texed (R30 s each for the precipitate-containing original tubes, hence-
forth P-tubes). Aliquots (2 3 10 ml, obtained from dilutions if necessary)
were taken from both sets of tubes and analyzed by the Bradford assay
[21], by using the appropriate background (0.5 M lactose in PBS for P-
tubes and 0.25M lactose in PBS for S-tubes). Aliquots (50 ml) were taken
directly from the S-tubes for analysis by UV-VIS spectroscopy at OD263
by using a microcuvette compared to a background of 0.25M lactose in
PBS. Aliquots (25 ml) from the P-tubes were added to 25 ml PBS and an-
alyzed by UV-VIS spectroscopy at OD263 by using a microcuvette com-
pared to a background of 0.25 M lactose in PBS.
Control experiments demonstrated that at the concentrations
tested, unless otherwise noted, the pseudopolyrotaxanes do not yield
a Bradford response above background. Thus, the Bradford response
in these samples was attributed solely to Gal-1 and was converted to
a molar concentration by comparison with an independently prepared
standard curve for Gal-1. Good correlations were obtained for the total
measured amounts of Gal-1 from the precipitate and remaining solu-
tion compared to the starting amount of Gal-1. While the Bradford
assay reported specifically on Gal-1, UV-VIS spectroscopy provided
a measure of the total concentration of both Gal-1 and pseudopoly-
rotaxane in the samples. The concentration of both Gal-1 and the
pseudopolyrotaxanes vary linearly with absorbance at 263 nm. The
molar absorptivities (3263) were obtained independently for Gal-1 and
each pseudopolyrotaxane. The concentration of Gal-1 in each sample
as determined by the Bradford assay was converted to an OD263 value
that was subtracted from the experimentally measured OD263 for each
sample. The remaining absorbance was assigned to pseudopolyrotax-
ane in the sample and was converted to a concentration by using the
3263 for that pseudopolyrotaxane. Using this method, good correla-
tions were obtained for the total measured amounts of pseudopolyro-
taxane from the precipitate and remaining solution compared to the
starting amount of pseudopolyrotaxane. Overall, the amounts of
Gal-1 and pseudopolyrotaxane measured independently from the
precipitate and the remaining solution agreed well with the total initial
concentrations. The results obtained from analyzing the precipitate are
presented in Figures 2 and 3. Each independent titration was per-
formed in duplicate, and three independent titrations were performed
for each assembly described.
Supplemental Data
Detailed synthetic procedures, characterization of polyviologens PV-8
and PV-21, and an example of a light scattering experiment (Figure S1)
are available at http://www.chembiol.com/cgi/content/full/14/10/
1140/DC1/.
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